Kalohexis

Private

Northbrook, IllinoisHealthcare & Life Scienceshttps://www.kalohexis.com/

Company Overview

Kalohexis is a clinical-stage biotechnology company that develops treatments for metabolic disorders such as obesity and cancer cachexia by harnessing the melanocortin system.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

peptide therapeuticsobesity treatmentMC3R/MC4R agonistoral obesity drugcancer cachexiaclinical-stage biotechmelanocortin systemdurable weight lossGLP-1 alternativeweight loss drugsmetabolic set-pointanti-obesity medicationMC3R/MC4R antagonistmetabolic disorderslean muscle massdrug discovery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kalohexis Comparables

Compare Kalohexis with similar companies based on industry and business-model similarity.

Kalohexis comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Endevica Bio	85%
Courage Therapeutics	82%
Kailera Therapeutics	68%

View all Comparables

Kalohexis Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Kalohexis Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Kalohexis Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Kalohexis's valuation, stock price, and market status.

Firmographic Details

HeadquartersNorthbrook, Illinois

Year Founded2026

Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?